Molecular Docking Optimization in the Context of Multi-Drug Resistant and Sensitive EGFR Mutants.

about

Molecular Docking Optimization in the Context of Multi-Drug Resistant and Sensitive EGFR Mutants.

Item

http://www.wikidata.org/entity/Q50545253

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Molecular Docking Optimization ...... nt and Sensitive EGFR Mutants.

@en

Molecular Docking Optimization ...... nt and Sensitive EGFR Mutants.

@nl

type

Item

label

Molecular Docking Optimization ...... nt and Sensitive EGFR Mutants.

@en

Molecular Docking Optimization ...... nt and Sensitive EGFR Mutants.

@nl

prefLabel

Molecular Docking Optimization ...... nt and Sensitive EGFR Mutants.

@en

Molecular Docking Optimization ...... nt and Sensitive EGFR Mutants.

@nl

P1476

Molecular Docking Optimization ...... ant and Sensitive EGFR Mutants

@en

P2093

José F Aldana-Montes

http://www.w3.org/2001/XMLSchema#string

P2860

The Protein Data Bank

Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor Sensitivity

Structural basis for the altered drug sensitivities of non-small cell lung cancer-associated mutants of human epidermal growth factor receptor

Binding mode of the breakthrough inhibitor AZD9291 to epidermal growth factor receptor revealed

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

UCSF Chimera--a visualization system for exploratory research and analysis

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

Comparative study of several algorithms for flexible ligand docking.

Lung adenocarcinoma harboring L858R and T790M mutations in epidermal growth factor receptor, with poor response to gefitinib: A case report

P31

scholarly article

P356

10.3390/MOLECULES21111575

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

María Jesús García-Godoy

Esteban López-Camacho

José García-Nieto

Antonio J. Nebro

P577

2016-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27869781

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

6274512

http://www.w3.org/2001/XMLSchema#string